Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Xinsifang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company headquartered in Zhoukou, Henan Province, specializing in the development and manufacturing of Traditional Chinese Medicine (TCM) and proprietary Chinese drugs. The company is widely recognized for its flagship product, the XiaoAiPing Tablet, a botanical extract of Marsdenia tenacissima that serves as an adjunctive treatment for various cancers, including esophageal and lung cancer. Henan Xinsifang operates modern GMP-certified facilities and is designated as a national high-tech enterprise, focusing on therapeutic areas such as oncology, hepatology, and musculoskeletal disorders. Its diverse product portfolio also includes Gantai Granules for liver health, Qianlietong Capsules for prostate conditions, and Agui Blood-Nourishing Syrup for anemia. By integrating traditional herbal knowledge with modern pharmacological research, the company aims to provide effective and safe treatment options for chronic and complex diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Xinsifang Pharmaceutical.